Dr. Simon BENITA

Simon Benita is a Professor at The Hebrew University of Jerusalem, where he received his Ph.D. in Pharmacy in 1980. His research is focused on polymeric nano- and microparticulate drug delivery systems aimed at improving the therapeutic performance of active ingredients.Prof. S. Benita formed and supervises a group of 32 M.Sc., 27 Ph.D. and 15 Post-Doctoral students in pharmaceutical sciences. He has published 149 research articles and 19 book chapters, edited or co-edited 5 books and been issued 16 patents and 10 patent applications. He was selected to be a recipient of The Hebrew University Kaye Innovation Award in 2000, 2005 and again in 2014, and is an AAPS Fellow.  He is the Founder of the company Novagali Pharma that received in 2009 the Siemens “Health Award”. Frost & Sullivan recognizes Novagali Pharma for Innovation in Ophthalmic Therapies and grants the 2009 Best Practices Award. Novagali has been listed in the Euronext in 2010 and acquired by Santen Japan in 2012.Chevalier dans l’Ordre National du Mérite (Knight in National Order of Merit), France, May 2012.Israel Controlled Release Society Chapter Prize for Outstanding Achievements in Controlled Release, September 2012.Director of the Institute for Drug Research and Head of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem (October 2010- September 2014).